Atul Saran
Plus aucun poste en cours
Fortune : 590 919 $ au 30/06/2024
Profil
Mr. Atul Saran is a Chief Executive Officer & Director at IntegerBio, Inc., a Member at The District of Columbia Bar and a Secretary & Director at Emergent Countermeasures International Ltd.
He is on the Board of Directors at IntegerBio, Inc., Emergent Product Development UK Ltd.
and Emergent Countermeasures International Ltd.
Mr. Saran was previously employed as an Executive VP, Chief Strategy & Development Officer by Emergent BioSolutions, Inc., a Senior Vice President & General Counsel by MacroGenics, Inc., a Vice President-Corporate Development & Ventures by AstraZeneca PLC, an Independent Director by Xencor, Inc., a Vice President-Corporate Development & Ventures by MedImmune LLC, a SVP-Corporate Development & Ventures by MedImmune Ventures, Inc., a Member by California State Bar Association, and an Associate Attorney by Hogan & Hartson LLP.
He also served on the board at Arriva Pharmaceuticals, Inc., Inotek Pharmaceuticals Corp.
and VentiRx Pharmaceuticals, Inc. He received his undergraduate degree from Stanford University, a graduate degree from the University of Illinois College of Law and an MBA from MIT Sloan School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/02/2023 | 86 645 ( 0,17% ) | 590 919 $ | 30/06/2024 |
Postes actifs de Atul Saran
| Sociétés | Poste | Début |
|---|---|---|
The District of Columbia Bar
 The District of Columbia Bar Miscellaneous Commercial ServicesCommercial Services The District of Columbia Bar provides legal services. The private company is based in Washington. | Corporate Officer/Principal | - |
Emergent Product Development UK Ltd.
 Emergent Product Development UK Ltd. Pharmaceuticals: MajorHealth Technology Emergent Product Development (UK) Ltd. develops oral vaccines for typhoid, traveler's diarrhea, hepatitis B, and anthrax. It also develops vaccines for meningitis and another for streptococcal infections for infants. The company is a biotechnology company focused on harnessing the immune system to treat and prevent disease in areas of significant unmet clinical needs. It was founded in 1996 and is located in Wokingham, UK. | Directeur/Membre du Conseil | 20/12/2017 |
Emergent Countermeasures International Ltd.
 Emergent Countermeasures International Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2015, Emergent Countermeasures International Ltd. is a British pharmaceutical company that manufactures pharmaceutical preparations. Part of Emergent BioSolutions, Inc., the company is based in Richmond, UK. | Directeur/Membre du Conseil | 18/12/2018 |
Anciens postes connus de Atul Saran
| Sociétés | Poste | Fin |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Conseiller Juridique Général | 01/03/2022 |
| MACROGENICS, INC. | Conseiller Juridique Général | 01/05/2017 |
| California State Bar Association | Corporate Officer/Principal | 15/05/2014 |
| XENCOR, INC. | Directeur/Membre du Conseil | 23/01/2014 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2014 |
Formation de Atul Saran
| Stanford University | Undergraduate Degree |
| University of Illinois College of Law | Graduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| XENCOR, INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| MACROGENICS, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
VentiRx Pharmaceuticals, Inc.
 VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | Health Technology |
| California State Bar Association | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Finance |
Hogan & Hartson LLP
 Hogan & Hartson LLP Miscellaneous Commercial ServicesCommercial Services Hogan & Hartson LLP provides legal services. Its is specialized in areas include energy, government contracts, immigration, and litigation. The company has offices in across Asia, Europe, Latin America and North America. Hogan & Hartston was founded in 1904 and is headquartered in Washington, DC. | Commercial Services |
The District of Columbia Bar
The District of Columbia Bar Miscellaneous Commercial ServicesCommercial Services The District of Columbia Bar provides legal services. The private company is based in Washington. | Commercial Services |
Arriva Pharmaceuticals, Inc.
 Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications. Arriva’s current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California. | Health Technology |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Health Technology |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Emergent Product Development UK Ltd.
Emergent Product Development UK Ltd. Pharmaceuticals: MajorHealth Technology Emergent Product Development (UK) Ltd. develops oral vaccines for typhoid, traveler's diarrhea, hepatitis B, and anthrax. It also develops vaccines for meningitis and another for streptococcal infections for infants. The company is a biotechnology company focused on harnessing the immune system to treat and prevent disease in areas of significant unmet clinical needs. It was founded in 1996 and is located in Wokingham, UK. | Health Technology |
Emergent Countermeasures International Ltd.
Emergent Countermeasures International Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2015, Emergent Countermeasures International Ltd. is a British pharmaceutical company that manufactures pharmaceutical preparations. Part of Emergent BioSolutions, Inc., the company is based in Richmond, UK. | Health Technology |
